{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:44:00Z","timestamp":1794008640145,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016970","name":"Consejer\u00eda de Econom\u00eda, Conocimiento, Empresas y Universidad, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["Proy_Excel_01002"],"award-info":[{"award-number":["Proy_Excel_01002"]}],"id":[{"id":"10.13039\/100016970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["C1-0003-2023"],"award-info":[{"award-number":["C1-0003-2023"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08374-w","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:24:27Z","timestamp":1780410267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospective germline exome and machine learning-based risk score identify predictive and prognostic biomarkers of immunotherapy outcomes in advanced non-small cell lung cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Andrea","family":"Gonz\u00e1lez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Onieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rivero-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Paz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rueda-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garrido-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mart\u00ednez-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Cristina","family":"Figueroa-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"P\u00e9rez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"8374_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"8374_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, et al. Pembrolizumab versus Chemotherapy for PD-L1\u2013Positive Non\u2013Small-Cell Lung Cancer. New Engl J Med Mass Med Soc. 2016;375:1823\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1606774.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"8374_CR3","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. N Engl J Med. 2018;378:2078\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1801005.","journal-title":"N Engl J Med"},{"key":"8374_CR4","doi-asserted-by":"publisher","first-page":"e2400075","DOI":"10.1200\/PO.24.00075","volume":"8","author":"J Wallenta Law","year":"2024","unstructured":"Wallenta Law J, Bapat B, Sweetnam C, Mohammed H, McBratney A, Izano MA, et al. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024;8:e2400075. https:\/\/doi.org\/10.1200\/PO.24.00075.","journal-title":"JCO Precis Oncol"},{"key":"8374_CR5","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","volume":"378","author":"MD Hellmann","year":"2018","unstructured":"Hellmann MD, Ciuleanu T-E, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, et al. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl J Med. 2018;378:2093\u2013104. https:\/\/doi.org\/10.1056\/NEJMoa1801946.","journal-title":"N Engl J Med"},{"key":"8374_CR6","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.3390\/cancers15184561","volume":"15","author":"W Cao","year":"2023","unstructured":"Cao W, Tang Q, Zeng J, Jin X, Zu L, Xu S. A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer. Cancers (Basel). 2023;15:4561. https:\/\/doi.org\/10.3390\/cancers15184561.","journal-title":"Cancers (Basel)"},{"key":"8374_CR7","doi-asserted-by":"publisher","first-page":"e011273","DOI":"10.1136\/jitc-2024-011273","volume":"13","author":"P Middha","year":"2025","unstructured":"Middha P, Thummalapalli R, Quandt Z, Balaratnam K, Cardenas E, Falcon CJ, et al. Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events. J Immunother Cancer. 2025;13:e011273. https:\/\/doi.org\/10.1136\/jitc-2024-011273.","journal-title":"J Immunother Cancer"},{"key":"8374_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-022-00345-6","volume":"7","author":"IS Chin","year":"2022","unstructured":"Chin IS, Khan A, Olsson-Brown A, Papa S, Middleton G, Palles C. Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity. npj Genom Med Nat Publishing Group. 2022;7:1\u201314. https:\/\/doi.org\/10.1038\/s41525-022-00345-6.","journal-title":"npj Genom Med Nat Publishing Group"},{"key":"8374_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.13253","volume":"318","author":"A Gusev","year":"2023","unstructured":"Gusev A. Germline mechanisms of immunotherapy toxicities in the GWAS era. Immunol Rev. 2023;318:138\u201356. https:\/\/doi.org\/10.1111\/imr.13253.","journal-title":"Immunol Rev"},{"key":"8374_CR10","doi-asserted-by":"publisher","first-page":"e003625","DOI":"10.1136\/jitc-2021-003625","volume":"10","author":"J Weidhaas","year":"2022","unstructured":"Weidhaas J, Marco N, Scheffler AW, Kalbasi A, Wilenius K, Rietdorf E, et al. Germline biomarkers predict toxicity to anti-PD1\/PDL1 checkpoint therapy. J Immunother Cancer. 2022;10:e003625. https:\/\/doi.org\/10.1136\/jitc-2021-003625.","journal-title":"J Immunother Cancer"},{"key":"8374_CR11","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1016\/j.csbj.2021.07.021","volume":"19","author":"A Monaco","year":"2021","unstructured":"Monaco A, Pantaleo E, Amoroso N, Lacalamita A, Lo Giudice C, Fonzino A, et al. A primer on machine learning techniques for genomic applications. Comput Struct Biotechnol J. 2021;19:4345\u201359. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.021.","journal-title":"Comput Struct Biotechnol J"},{"key":"8374_CR12","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.3390\/ijms24097781","volume":"24","author":"Q Al-Tashi","year":"2023","unstructured":"Al-Tashi Q, Saad MB, Muneer A, Qureshi R, Mirjalili S, Sheshadri A, et al. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. Int J Mol Sci. 2023;24:7781. https:\/\/doi.org\/10.3390\/ijms24097781.","journal-title":"Int J Mol Sci"},{"key":"8374_CR13","doi-asserted-by":"publisher","first-page":"100767","DOI":"10.1016\/j.oor.2025.100767","volume":"16","author":"R Bhushan","year":"2025","unstructured":"Bhushan R, Rai S, Jangra P, Sonker P, Singh N, Lakshami R, et al. The role of artificial intelligence in predicting cancer immunotherapy response. Oral Oncol Rep. 2025;16:100767. https:\/\/doi.org\/10.1016\/j.oor.2025.100767.","journal-title":"Oral Oncol Rep"},{"key":"8374_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/jamaoncol.2024.5356","volume":"11","author":"M Rakaee","year":"2025","unstructured":"Rakaee M, Tafavvoghi M, Ricciuti B, Alessi JV, Cortellini A, Citarella F, et al. Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer. JAMA Oncol. 2025;11:109\u201318. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5356.","journal-title":"JAMA Oncol"},{"key":"8374_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"8374_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/0471250953.bi1110s43","volume":"11","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinf. 2013;11:11. https:\/\/doi.org\/10.1002\/0471250953.bi1110s43.","journal-title":"Curr Protoc Bioinf"},{"key":"8374_CR17","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","journal-title":"Bioinformatics"},{"key":"8374_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303. https:\/\/doi.org\/10.1101\/gr.107524.110.","journal-title":"Genome Res"},{"key":"8374_CR19","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1158\/0008-5472.CAN-17-0338","volume":"77","author":"DL Masica","year":"2017","unstructured":"Masica DL, Douville C, Tokheim C, Bhattacharya R, Kim R, Moad K, et al. CRAVAT 4: Cancer-Related Analysis of Variants Toolkit. Cancer Res. 2017;77:e35\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0338.","journal-title":"Cancer Res"},{"key":"8374_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nat Nat Publishing Group. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nat Nat Publishing Group"},{"key":"8374_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Nat Publishing Group. 2015;17:405\u201323. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med Nat Publishing Group"},{"issue":"8099","key":"8374_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s41586-025-10014-0","volume":"649","author":"\u017d Avsec","year":"2026","unstructured":"Avsec \u017d, Latysheva N, Cheng J, Novati G, Taylor KR, Ward T, et al. Advancing regulatory variant effect prediction with AlphaGenome. Nature. 2026;649(8099):1206\u201318. https:\/\/doi.org\/10.1038\/s41586-025-10014-0.","journal-title":"Nature"},{"key":"8374_CR23","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"issue":"2","key":"8374_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","volume":"54","author":"RW Sayaman","year":"2021","unstructured":"Sayaman RW, Saad M, Thorsson V, et al. Germline genetic contribution to the immune landscape of cancer. Immunity. 2021;54(2):367\u2013e3868. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.011.","journal-title":"Immunity"},{"issue":"10","key":"8374_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley MS, Crocker PR, Paulson JC. Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol. 2014;14(10):653\u201366. https:\/\/doi.org\/10.1038\/nri3737.","journal-title":"Nat Rev Immunol"},{"key":"8374_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","volume":"38","author":"S Duan","year":"2020","unstructured":"Duan S, Paulson JC. Siglecs as Immune Cell Checkpoints in Disease. Annu Rev Immunol. 2020;38:365\u201395. https:\/\/doi.org\/10.1146\/annurev-immunol-102419-035900.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"8374_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7(4):255\u201366. https:\/\/doi.org\/10.1038\/nri2056.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"8374_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jaci.2014.11.031","volume":"135","author":"BS Bochner","year":"2015","unstructured":"Bochner BS, Zimmermann N. Role of siglecs and related glycan-binding proteins in immune responses and leukocyte therapeutics. J Allergy Clin Immunol. 2015;135(3):598\u2013608. https:\/\/doi.org\/10.1016\/j.jaci.2014.11.031.","journal-title":"J Allergy Clin Immunol"},{"key":"8374_CR29","doi-asserted-by":"publisher","first-page":"e010162","DOI":"10.1136\/jitc-2024-010162","volume":"13","author":"J Yin","year":"2025","unstructured":"Yin J, Lu Y, Liu Y, Shi Q, Shi M, Zhu Z, et al. SIGLEC11 promotes M2 macrophage polarization through AKT-mTOR signaling and facilitates the progression of gastric cancer. J Immunother Cancer. 2025;13:e010162. https:\/\/doi.org\/10.1136\/jitc-2024-010162.","journal-title":"J Immunother Cancer"},{"key":"8374_CR30","doi-asserted-by":"publisher","first-page":"216224","DOI":"10.1016\/j.canlet.2023.216224","volume":"565","author":"B Feng","year":"2023","unstructured":"Feng B, Pan B, Huang J, Du Y, Wang X, Wu J, et al. PDE4D\/cAMP\/IL-23 axis determines the immunotherapy efficacy of lung adenocarcinoma via activating the IL-9 autocrine loop of cytotoxic T lymphocytes. Cancer Lett. 2023;565:216224. https:\/\/doi.org\/10.1016\/j.canlet.2023.216224.","journal-title":"Cancer Lett"},{"key":"8374_CR31","doi-asserted-by":"publisher","first-page":"1528932","DOI":"10.3389\/fimmu.2025.1528932","volume":"16","author":"H-L Ren","year":"2025","unstructured":"Ren H-L, Zhang S-H, Li P-Y. The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy. Front Immunol. 2025;16:1528932. https:\/\/doi.org\/10.3389\/fimmu.2025.1528932.","journal-title":"Front Immunol"},{"issue":"9","key":"8374_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrg3502","volume":"14","author":"M Parkes","year":"2013","unstructured":"Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet. 2013;14(9):661\u201373. https:\/\/doi.org\/10.1038\/nrg3502.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"8374_CR33","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1002\/art.41068","volume":"71","author":"A Tison","year":"2019","unstructured":"Tison A, Qu\u00e9r\u00e9 G, Misery L, Funck-Brentano E, Danlos FX, Routier E, et al. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study. Arthritis Rheumatol. 2019;71(12):2100\u201311. https:\/\/doi.org\/10.1002\/art.41068.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"8374_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7326\/M17-2073","volume":"168","author":"N Abdel-Wahab","year":"2018","unstructured":"Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse Events in Cancer Patients with Preexisting Autoimmune Disorders Receiving Immune Checkpoint Inhibitors: A Systematic Review. Ann Intern Med. 2018;168(2):121\u201330. https:\/\/doi.org\/10.7326\/M17-2073.","journal-title":"Ann Intern Med"},{"key":"8374_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejca.2017.12.008","volume":"91","author":"FX Danlos","year":"2018","unstructured":"Danlos FX, Voisin AL, Dyevre V, Michot JM, Routier E, Taillade L, et al. Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease. Eur J Cancer. 2018;91:21\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2017.12.008.","journal-title":"Eur J Cancer"},{"key":"8374_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41577-021-00500-7","volume":"21","author":"R El Masri","year":"2021","unstructured":"El Masri R, Delon J. RHO GTPases: from new partners to complex immune syndromes. Nat Rev Immunol. 2021;21:499\u2013513. https:\/\/doi.org\/10.1038\/s41577-021-00500-7.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"8374_CR37","doi-asserted-by":"publisher","first-page":"790802","DOI":"10.1016\/j.tcb.2021.08.002","volume":"31","author":"R Chen","year":"2021","unstructured":"Chen R, Chen L. Solute carrier transporters: emerging central players in tumour immunotherapy. Trends Cell Biol. 2021;31(10):790802. https:\/\/doi.org\/10.1016\/j.tcb.2021.08.002.","journal-title":"Trends Cell Biol"},{"key":"8374_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-016-0287-7","volume":"23","author":"H-T Tzeng","year":"2016","unstructured":"Tzeng H-T, Wang Y-C. Rab-mediated vesicle trafficking in cancer. J Biomed Sci. 2016;23:70. https:\/\/doi.org\/10.1186\/s12929-016-0287-7.","journal-title":"J Biomed Sci"},{"key":"8374_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12920-016-0218-1","volume":"9","author":"NA Abdul Aziz","year":"2016","unstructured":"Abdul Aziz NA, Mokhtar NM, Harun R, Mollah MMH, Mohamed Rose I, Sagap I, et al. A 19-Gene expression signature as a predictor of survival in colorectal cancer. BMC Med Genomics. 2016;9:58. https:\/\/doi.org\/10.1186\/s12920-016-0218-1.","journal-title":"BMC Med Genomics"},{"key":"8374_CR40","doi-asserted-by":"publisher","first-page":"e0223371","DOI":"10.1371\/journal.pone.0223371","volume":"14","author":"C Udagawa","year":"2019","unstructured":"Udagawa C, Horinouchi H, Shiraishi K, Kohno T, Okusaka T, Ueno H, et al. Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease. PLoS ONE. 2019;14:e0223371. https:\/\/doi.org\/10.1371\/journal.pone.0223371.","journal-title":"PLoS ONE"},{"key":"8374_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12859-023-05540-5","volume":"24","author":"HY Zengin","year":"2023","unstructured":"Zengin HY, Karabulut E. Biomarker detection using corrected degree of domesticity in hybrid social network feature selection for improving classifier performance. BMC Bioinformatics. 2023;24:407. https:\/\/doi.org\/10.1186\/s12859-023-05540-5.","journal-title":"BMC Bioinformatics"},{"key":"8374_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12859-023-05267-3","volume":"24","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhou Y, Takagi T, Song J, Tian Y-S, Shibuya T. Genetic algorithm-based feature selection with manifold learning for cancer classification using microarray data. BMC Bioinformatics. 2023;24:139. https:\/\/doi.org\/10.1186\/s12859-023-05267-3.","journal-title":"BMC Bioinformatics"},{"key":"8374_CR43","doi-asserted-by":"publisher","unstructured":"Hauskrecht M, Pelikan R, Valko M, Lyons-Weiler J. Feature selection and dimensionality reduction in genomics and proteomics. In: Werner Dubitzky MG, Berrar D, editors. Fundamentals of Data Mining in Genomics and Proteomics. Springer; 2006. pp. 149\u201372. https:\/\/doi.org\/10.1007\/978-0-387-47509-7.","DOI":"10.1007\/978-0-387-47509-7"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08374-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08374-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08374-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:04:04Z","timestamp":1786057444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08374-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8374"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08374-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8455214\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Provincial Research Ethics Committee of M\u00e1laga (PEIBA), reference number 26-10-2017. Written informed consent was obtained from all participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have provided consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1006"}}